Filing Details
- Accession Number:
- 0001501134-20-000080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-16 21:30:06
- Reporting Period:
- 2020-11-13
- Accepted Time:
- 2020-11-16 21:30:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1689575 | Katherine Stueland | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-13 | 1,000 | $48.00 | 237,352 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 22, 2019.
- Includes an aggregate of 166,973 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Billionaire Hedge Funds
